Chapter 1: Choosing Our Bodies Gene therapy from Ashanti DeSilva (
the first human patient) to boosting strength, speed, and stamina.
Not exact matches
In 2000, Medarex began its
first phase of
human testing on its new «CTLA -4-blockade» — in
patients who had either prostate cancer or metastatic melanoma, a deadly form of skin cancer.
Johnny Ray, who died on this date six years ago, was Kennedy's
patient, his research subject, and the world's
first human cyborg, fitted with brain implants that allowed him to communicate directly with a computer.
The
first - in -
human PET / CT imaging of 75
patients with 18F - MPG was performed to show that this tracer can be used as a companion diagnostic to identify NSCLC
patients with EGFR activating mutant tumors (primary tumor or metastatic) with 84.3 % accuracy.
They found that, within the
first three days of injury, fish in the concussion group were slower to find a school of fish with which they previously swam, a measure of spatial memory which is impaired in other animal models of concussion and
human patients.
Horvath and Tell's research is the
first reported study to compare breast cancer subtypes and gene expression patterns associated with STAT3 in the tumors of
human patients.
«The ABICABAZI trial puts these ideas to the test in
humans, and if we are correct, has the capacity for the
first time to tell us what
patients might most benefit from chemotherapy.»
Clinicians treating
patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus (MERS - CoV), a virus
first detected in
humans in 2012 that has since caused 614 laboratory - confirmed infections, including 181 that were fatal, according to the World Health Organization.
2015 will see the start of the
first human clinical trial of a gene silencing or huntingtin - lowering drug, which specifically aims to reduce production of mutant huntingtin in the brains of HD
patients.
The students» prototype, developed during a yearlong biomedical engineering master's degree program, has not yet been tested on
humans, but it is viewed as a promising
first step toward helping Parkinson's
patients safely relieve their own symptoms at home or elsewhere without going to a hospital or doctor's office.
These images provide the
first 3D ultrastructural details on HIV infection and virus production in a setting that closely resembles the gut of
human patients.
The team at UF's Powell Center for Rare Disease Research and Therapy conducted the
first in -
human study of gene therapy to treat respiratory dysfunction in
patients with infantile onset Pompe.
But to try the treatment in
patients, they will have to identify the mouse proteins»
human equivalents
first.
An antibody engineered to prevent excessive bleeding in
patients with severe hemophilia A may be safe and effective, and require fewer injections than existing options, according to a
first - in -
human study of the treatment published online today in Blood, the Journal of the American Society of Hematology (ASH).
«This is the
first study advancing barrier repair that treats symptomatic mice, which more closely mirrors conditions for
human patients,» Dr. Garbuzova - Davis said.
«Antibody for severe hemophilia a may reduce injections needed to prevent bleeding:
First - in -
human study of ACE910 suggests excessive bleeding prevention is possible with a weekly subcutaneous injection compared to standard two or three intravenous injections every week, and should be effective in treating
patients with inhibitors.»
Liv Bode, a virologist at the Robert Koch Institut in Berlin whose team was the
first to isolate the virus from
patients, welcomes the findings as a «solid piece of work that fits the picture and lends further support to the existence of
human [strains of] BDV.»
The study was the
first to create
human Purkinje cells using TSC
patients» own stem cells.
In the
first published results from a clinical trial using
human embryonic stem cells, two legally blind
patients who received an injection of hESC - derived cells in one eye have experienced no harmful side effects and appear to have slightly better vision.
«Based on this research, we are now conducting a
first - in -
human study combining the PARP inhibitor with radiation and chemotherapy in
patients with locally advanced pancreatic cancer, with an ultimate goal of improving survival rates and treatment outcomes,» said Tuli.
One team in Japan, and another in the US, have independently shown it is possible to produce embryonic - like stem cells directly from a
patient's own skin cells without having to create and destroy a cloned
human embryo
first.
The lawsuit against Myriad Genetics and the University of Utah Research Foundation, which hold the patents on the genes, charged that the challenged patents are illegal and restrict both scientific research and
patients» access to medical care, and that patents on
human genes violate the
First Amendment and patent law because genes are «products of nature.»
«This is the
first human trial of this novel stem cell - based implant, which is designed to replace a single - cell layer that degenerates in
patients with dry age - related macular degeneration,» says lead author and surgeon for the study Dr. Amir H. Kashani, assistant professor of clinical ophthalmology at the Keck School of Medicine of USC.
Our team was instrumental in the development of talimogene laherparepvec, the
first in
human oncolytic virus therapy for
patients with melanoma.
Geron became the
first company to start clinical trials of embryonic stem cells in
humans, starting with a
patient who had spinal cord injuries.
About OpenBiome OpenBiome is the
first public stool bank, founded to expand safe access to fecal transplantation for
patients with recurrent C. difficile infection and to catalyze research on the microbiome's role in
human health.
Daniel Speiser, Pedro Romero, and colleauges report the
first demonstration in
humans that a synthetic vaccine can rapidly elicit strong specific CD8 + T cell responses in a majority of
patients.
Which
patient groups should be asked to participate in
first - in -
human trials of stem cell - based therapies?
Researchers at UCLA treat the
first patients in the second FDA - approved study evaluating a therapy made from
human embryonic stem cells.
In 1988, Freed and his colleague Robert Breeze, MD, performed the
first transplant of
human fetal dopamine cells into a Parkinson's
patient in the United States.
Russell Kern reports on the 6 - month update on the
first - in -
human clinical study of neural stem cells in
patients with Parkinson's disease.
The
Human Trial is following one research team and a handful of trial
patients as they move from the lab through the
first two years of the Phase 1/2 clinical trial.
Researchers have treated the
first two
patients in the second government - authorized attempt to evaluate a therapy created using
human embryonic stem cells in the United States.
The
first trials would primarily assess safety but would also begin to probe what really happens inside a
human heart, perhaps through testing in
patients scheduled for heart transplantation, allowing scientists to study their old hearts post-transplant.
October 13, 2016 Researchers help paralyzed man regain sense of touch through a robotic arm For the
first time ever, a
human patient is able to experience the sense of touch through a robotic arm that he controls with his brain, with the help of technology created by researchers from Pitt and UChicago's Sliman Bensmaia.
All six
patients suffered from end - stage heart disease and were enrolled in this
first - in -
human (FIH) clinical trial, approved by the U.S. Food and Drug Administration in late 2015.
«Our approach allowed us to grow
human neurons in a dish that contained the exact same mutation as the neurons in the brain of the
patient,» explained
first author Helen Fong, PhD, who is also a California Institute for Regenerative Medicine postdoctoral scholar.
•
Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant cardiac disease; uncontrolled hypertension • Left ventricular ejection fraction (LVEF) < 45 % • Allogeneic stem cell transplant within 100 days before
first dose of study drug • Known history of
human immunodeficiency virus (HIV) infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting cancer that is distinct in primary site or histology from the cancer evaluated in this study • Serious, uncontrolled infection • Unresolved chronic toxicity > grade 1 from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study
He and his colleagues were the
first to demonstrate that
human antigen - specific T cell clones could be isolated and expanded in vitro and then re-infused into
patients to prevent or treat viral infections and to mediate therapeutic responses in
patients with cancer.
The
first patients to receive
human embryonic stem cell transplants say their lives have been transformed by the experimental procedure
In the several years since those
first reports, new advances in the derivation of hiPSCs from various tissue sources (including those from
human patients) and using diverse reprogramming techniques, and in their use as a pluripotent cell source in the induced differentiation of a wide array of somatic cell types, have appeared with almost startling rapidity.
She was the Director of the Center for
Human Genetics from 2000 to 2008, Medical Director of the Clinical Cancer Genetics program from 1995 to 2012, and founded the
first specialized clinic for delivery of genetic services to
patients and families with hereditary cancer susceptibility in Northeastern Ohio.
Yerkes National Primate Research Center researchers are the
first to show that an irradiation plus transplantation combination approach in nonhuman primates can be used to treat or even possibly cure HIV / AIDS, and this new model is providing some answers about the «Berlin
patient,» the only
human thought cured of AIDS.
Details of a
first - in -
human case report showed that a
patient with melanoma was able to achieve a durable complete response with the combination of two types of immunotherapy.
In the
first of the two new studies, Lobo and his team showed that they could obtain lung spheroid cells from
human lung disease
patients with a relatively non-invasive procedure called a transbronchial biopsy.
While this
first study was done on rats, a previous study performed by Safarinejad studied stinging nettle's effects on BPH in
human patients.
At
first, I had difficulty believing what I was reading, but it's true and you can read more information about the study on clinicaltrials.gov: Inoculating Celiac Disease
Patients With the
Human Hookworm Necator Americanus: Evaluating Immunity and Gluten - sensitivity.
I am currently working to complete my master's degree in
Human Nutrition and Functional Medicine from the University of Western States, a science - based and
patient - centered approach to health that focuses on treating the person by
first assessing the underlying cause of disease.
April 18, 2018 • The
first single from the metal band's fourth album, Ordinary Corrupt
Human Love, offers a gift for the
patient Deafheaven listener.
Laser therapy was
first used on
human patients and now it is gradually being adapted as a valuable component of veterinary technology.